Skip to content

LENSAR, Inc. LNSR Debt-to-equity

Debt-to-equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.7×0.0×
Staar Surgical logo
Staar SurgicalSTAA
0.1×0.0×
Bausch + Lomb logo
Bausch + LombBLCO
0.8×0.0×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.4×+3.2×
IAR
Integra LifeSciencesIART
1.9×+0.6×
ITG
Integer HoldingsITGR
0.8×0.0×

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on the most recent quarter.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s debt-to-equity?
LENSAR, Inc. (LNSR) reported debt-to-equity of 0.7× in Q1 2026.
What is the long-term trend for LENSAR, Inc.'s debt-to-equity?
Over 4 years (2020 to 2024), LENSAR, Inc.'s debt-to-equity has grown at a 75.6% compound annual growth rate (CAGR), from 0.1× to 0.5×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.